100 related articles for article (PubMed ID: 8143277)
1. Double minute chromosomes in an invasive adenocarcinoma of the prostate.
Milasin J; Mićić S
Cancer Genet Cytogenet; 1994 Feb; 72(2):157-9. PubMed ID: 8143277
[TBL] [Abstract][Full Text] [Related]
2. Double minutes in two primary adenocarcinomas of the prostate.
Limon J; Lundgren R; Elfving P; Heim S; Kristoffersson U; Mandahl N; Mitelman F
Cancer Genet Cytogenet; 1989 Jun; 39(2):191-4. PubMed ID: 2752372
[TBL] [Abstract][Full Text] [Related]
3. Chromosome rearrangements in a metastatic adenocarcinoma of the prostate.
Gibas Z; Pontes JE; Sandberg AA
Cancer Genet Cytogenet; 1985 Apr; 16(4):301-4. PubMed ID: 3978598
[TBL] [Abstract][Full Text] [Related]
4. Frequency and pattern of karyotypic abnormalities in human prostate cancer.
Brothman AR; Peehl DM; Patel AM; McNeal JE
Cancer Res; 1990 Jun; 50(12):3795-803. PubMed ID: 2340524
[TBL] [Abstract][Full Text] [Related]
5. Chromosome changes in benign prostatic hyperplasia and their significance in the origin of prostatic carcinoma.
Casalone R; Portentoso P; Granata P; Minelli E; Righi R; Meroni E; Pozzi E; Chiaravalli AM
Cancer Genet Cytogenet; 1993 Jul; 68(2):126-30. PubMed ID: 7689034
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability.
Micale MA; Mohamed A; Sakr W; Powell IJ; Wolman SR
Cancer Genet Cytogenet; 1992 Jul; 61(2):165-73. PubMed ID: 1638499
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic studies of prostatic cancer.
Lundgren R
Scand J Urol Nephrol Suppl; 1991; 136():1-35. PubMed ID: 1871551
[TBL] [Abstract][Full Text] [Related]
8. Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an adenocarcinoma of the prostate.
Lundgren R; Kristoffersson U; Heim S; Mandahl N; Mitelman F
Cancer Genet Cytogenet; 1988 Oct; 35(1):103-8. PubMed ID: 3180000
[TBL] [Abstract][Full Text] [Related]
9. Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: paraffin FISH vs. metaphase analysis.
Micale MA; Sanford JS; Powell IJ; Sakr WA; Wolman SR
Cancer Genet Cytogenet; 1993 Aug; 69(1):7-12. PubMed ID: 8374904
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic analysis of four primary prostatic cultures.
Brothman AR; Lesho LJ; Somers KD; Schellhammer PF; Ladaga LE; Merchant DJ
Cancer Genet Cytogenet; 1989 Feb; 37(2):241-8. PubMed ID: 2467737
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic evaluation of 20 cultured primary prostatic tumors.
Brothman AR; Peehl DM; Patel AM; MacDonald GR; McNeal JE; Ladaga LE; Schellhammer PF
Cancer Genet Cytogenet; 1991 Aug; 55(1):79-84. PubMed ID: 1913611
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic survey of 32 cancers of the prostate.
Arps S; Rodewald A; Schmalenberger B; Carl P; Bressel M; Kastendieck H
Cancer Genet Cytogenet; 1993 Apr; 66(2):93-9. PubMed ID: 8500107
[TBL] [Abstract][Full Text] [Related]
13. Deletion (1)(q12) and double minutes in a metastatic adenocarcinoma of the prostate.
Carvalho-Salles AB; Mesquita JC; Tajara EH
Cancer Genet Cytogenet; 2000 Jan; 116(1):50-3. PubMed ID: 10616533
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic study of four cancers of the prostate.
Babu VR; Miles BJ; Cerny JC; Weiss L; Van Dyke DL
Cancer Genet Cytogenet; 1990 Aug; 48(1):83-7. PubMed ID: 2372791
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic and ploidy analysis of prostatic adenocarcinoma.
Perlman EJ; Epstein JI; Long PP; Pizov G; Griffin CA
Mod Pathol; 1993 May; 6(3):348-52. PubMed ID: 8346183
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic abnormalities are frequent in uncultured prostate cancer cells.
Webb HD; Hawkins AL; Griffin CA
Cancer Genet Cytogenet; 1996 Jun; 88(2):126-32. PubMed ID: 8640720
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic characterization of an established xenografted prostatic adenocarcinoma cell line (PC-82).
König JJ; Hagemeijer A; Smit B; Kamst E; Romijn JC; Schröder FH
Cancer Genet Cytogenet; 1988 Aug; 34(1):91-9. PubMed ID: 3395997
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours.
Alers JC; Krijtenburg PJ; Hop WC; Bolle WA; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
J Pathol; 1998 Jul; 185(3):273-83. PubMed ID: 9771481
[TBL] [Abstract][Full Text] [Related]
19. Specific cytogenetic aberrations in two novel human prostatic cell lines immortalized by human papillomavirus type 18 DNA.
Weijerman PC; van Drunen E; König JJ; Teubel W; Romijn JC; Schröder FH; Hagemeijer A
Cancer Genet Cytogenet; 1997 Dec; 99(2):108-15. PubMed ID: 9398864
[TBL] [Abstract][Full Text] [Related]
20. Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts.
Williams BJ; Jones E; Kozlowski JM; Vessella R; Brothman AR
Genes Chromosomes Cancer; 1997 Apr; 18(4):299-304. PubMed ID: 9087570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
